PEP-Therapy values collaborations and partnerships with pharma and biotech partners, clinical organizations and investors to accelerate the development of PEP-010, as well as its pipeline of peptide-based products through co-development or licensing-in programs.

PEP-Therapy is currently strengthening its pipeline of peptide-based products in oncology through co-developments or licensing-in programs with academic institutions and biotech companies.

+ products

For partnering opportunities, please contact us.

+ contact